FDA releases guidance on bioavailability and bioequivalence study samples
The FDA has released guidance on its compliance policy on reserve samples used in bioavailability and bioequivalence studies.
List view / Grid view
The FDA has released guidance on its compliance policy on reserve samples used in bioavailability and bioequivalence studies.
19 August 2020 | By B&W Tek, A Metrohm Group Company
In this on-demand webinar, development groups will learn how analysis with quantitative transmission Raman aids in formulation development and process development, Register today to learn more!
Dr Stephane Gobron explores three different ways that manufacturers can use to bring their PPE up to regulatory standard.
A study has found that three prescription drugs on the market cause unexpected side effects in the C. elegans worm, meaning they could have unknown effects in humans.
This whitepaper studies the effect of humidity on tablet surfaces containing different types of super disintegrants.
Superdisintegrants are categorised by their mechanism of action such as wicking, swelling or shape recovery. In this study, the performance of disintegrants from each of these groups was tested in an insoluble, hydrophobic tablet formulation.
Grant Courtney explains why traceability is vital for the current pandemic as it would guarantee that COVID-19 vaccines are safe, effective and suitably distributed.
Watch how PROSOLV® EASYtab, the all-in-one excipient composite, offers superior disintegration for your tablet formulations.
Discover JRS PHARMA's industry leading manufacturing network for Microcrystalline Cellulose.
Randox is recalling COVID-19 testing kits in the UK as a precautionary measure as they do not meet the required safety standards, the MHRA has said.
The 'One Million Post-Authorisation Study' has been established to monitor the safety and effectiveness of COVID-19 vaccines in real-life conditions.
The International Air Cargo Association and Pharma.Aero will form a joint working group to provide air cargo guidance to the logistics industry for the transportation of COVID-19 vaccines.
A new report has outlined that AstraZeneca has been granted protection from product liability claims regarding its COVID-19 vaccine candidate.
NICE has issued draft guidance that does not recommend chlormethine gel for mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL).
NICE has said commonly used treatments for chronic primary pain such as paracetamol have little or no evidence that they work and should not be prescribed for the condition.